Guardant Health, Inc. (GH) Quarterly Sales Growth

Symbol and logo of brand Guardant Health Inc (GH)

Guardant Health, Inc. (GH) is a leading innovator in liquid biopsy, bringing together elite geneticists to save lives. A robust patent portfolio provides the company with a technological edge and protects its market share. Strategic alliances with pharmaceutical behemoths accelerate the launch of clinical tests. The quarterly revenue growth rate demonstrates business dynamics, where the current level is approximately 35.60, helping investors identify the asset's development phase in advance.

GH (Guardant360) Quarterly Revenue Growth history from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Guardant Health (GH)

- stock price and consensus target price:
Analysis of all company metrics:GH - Guardant Health
Manufactured products of guardanthealth.com

Guardant Health, Inc. (GH) maintains its leadership in oncology by scaling liquid biopsy for targeted therapy. By analyzing quarterly revenue growth rates, investors assess operational sales dynamics adjusted for fiscal factors, where the current value of 35.60 serves as an indicator of market adoption and determines the risk of capital drawdown should business expansion slow.